Investigación Biomédica para el Desarrollo de Fármacos S.A. de C.V. (BIOMED-GDL)

Academic/Hospital

Also known as: Investigación Biomédica para el Desarrollo de Fármacos S.A. de C.V. (BIOMED-GDL) | Investigación Biomédica para el Desarrollo de Fármacos S.A. de C.V. (IBIOMED-AGS) | Investigación Biomédica para el Desarrollo de Fármacos, S.A de C.V. (IBIOMED-GDL)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Jun 30, 2021

Last known activity

Aug 31, 2021

Timeline

No events for the selected filters.

Drugs by trial phase (6 distinct, 3 trials)

Phase 3 (6 own, 0 via acquisition)

metformin
chlorthalidone
atorvastatin
losartan
fenofibrate
hydrochlorothiazide

Recent trials (3)

NCT04943692Overall official - principal investigatorPhase 3Aug 31, 2021
NCT04927299Overall official - principal investigatorPhase 3Jun 30, 2021
NCT04882293Overall official - principal investigatorPhase 3Jun 30, 2021

Details

Last known activity: Aug 31, 2021